Alfa 1 antitrypsin deficit: only COPD or asthma as well?

Mario Cazzola (Italy)

Source: ERS Course 2019 - Masterclass in airways disease 2019
Number: 14
Disease area: Airway diseases

Slide presentationPDF journal article, handout or slidesWebcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mario Cazzola (Italy). Alfa 1 antitrypsin deficit: only COPD or asthma as well?. ERS Course 2019 - Masterclass in airways disease 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil
Source: Eur Respir J 2003; 22: Suppl. 45, 499s
Year: 2003

Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in!
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020

Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020

Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD)
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011

Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014

Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

The effect of posture on ventilation using SLP in healthy subject and patients with Alpha 1 anti-trypsin deficiency (A1AT)
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014

Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

Difficult-to-treat asthma: how serious is the problem and what are the issues?
Source: Eur Respir Mon 2011; 51: 1-15
Year: 2011

The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015

Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013

Relationship between atopy, asthma and alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Low vitamin D level and adult-onset bronchial asthma: Is there a link?
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015

Ventilation heterogeneity reversibility: asthma, COPD or ACOS?
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017